APA

Pong Y., Su Y., Lo H., Ho C., Hsieh C., Chu C., Chen-Yang Y. W., Tsai V. F. S., Wu J. & Wu G. (20201120). METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay. : Cancer biomarkers : section A of Disease markers.

Chicago

Pong Yuan-Hung, Su Yann-Rong, Lo Hsing-Wen, Ho Chung-Kun, Hsieh Chia-Chi, Chu Ching-Tung, Chen-Yang Yui Whei, Tsai Vincent F S, Wu Jui-Chuang and Wu Guang-Jer. 20201120. METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay. : Cancer biomarkers : section A of Disease markers.

Harvard

Pong Y., Su Y., Lo H., Ho C., Hsieh C., Chu C., Chen-Yang Y. W., Tsai V. F. S., Wu J. and Wu G. (20201120). METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay. : Cancer biomarkers : section A of Disease markers.

MLA

Pong Yuan-Hung, Su Yann-Rong, Lo Hsing-Wen, Ho Chung-Kun, Hsieh Chia-Chi, Chu Ching-Tung, Chen-Yang Yui Whei, Tsai Vincent F S, Wu Jui-Chuang and Wu Guang-Jer. METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay. : Cancer biomarkers : section A of Disease markers. 20201120.